Clinical trials recruiting for Cancer of the Pancreas
3
Recruiting trials
1
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Avutometinib | 1 |
| Defactinib | 1 |
| Stereotactic body radiotherapy | 1 |
| Zunsemetinib | 1 |
| mFOLFIRINOX | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Missouri | 3 |
Top cities
Self-screener
Recruiting trials
- MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
- Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
Related conditions
Trials recruiting for Cancer of the Pancreas often also study these conditions. Each links to its own recruiting-trial list.
Pancreatic cancer 870Pancreas Cancer 86Pancreatic Adenocarcinoma 49Metastatic Pancreatic Ductal Adenocarcinoma 12Locally Advanced Pancreatic Cancer 9Cervical cancer 71
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Cancer of the Pancreas trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.